7:30 p.m. Two presentations! Richard Cathcart, longtime Ottawa Member and former Chairman began the discussion with a status report on the new partial androgen blockade being provided by Degarelix (Firmagon) instead of Goserelin (Zoladex, AstrZeneca). Goserelin, over the past 15 years, was able to reduce Richard's PSA from 89 upon diagnosis in 1995 to 0.200--virtually negligible. But about 8 months ago his PSA level started to rise appreciably to about 13. So oncologist Libni Eapen suggested a research effort using Degarelix. This trial is being coordinated by Dr. Shawn Malone at the Ottawa Regional Cancer Centre. (See video, below.
Peter Maddocks, a new member of PCCN, spoke about his own diagnosis and intitial treatment. Peter also reviewed an excellent new DVD compilation of survivor stories entitled "Men Talking to Men about Prostate Cancer: An interactive DVD that addresses what MEN at various points along the cancer trajectory think other MEN should know." The DVD was funded by the Grand River Motorcycle Ride for Dad, supported by the Grand River Regional Cancer Centre, PCCN Oakville-Mississauga, HopeSpring Cancer Support Centre, Wellspring Halton-Peel, Guelph-Wellington Prostate Cancer Support Group, and the Owen Sound Hospital. The DVD can also be viewed online.